Breast cancer statistics

Breast Cancer Metastasis and Drug Resistance: Progress and Prospects

Volumn , Issue , 2013, Pages 1-18

  Ma, Jiemin ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

5 year relative survival; Age; Age standardized rate (ASR); Breast cancer; Cancer burden; Cancer incidence; Cancer mortality; Cancer statistics; Geographic variation; Global patterns; Race ethnicity; Socioeconomic status (SES); Trends

Indexed keywords

EID: 84949178714     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-5647-6_1     Document Type: Chapter

References (53)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62(1): 10-29
2. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer epidemiology, biomarkers and prevention: A publication of the American association for cancer research, cosponsored by the American society of preventive oncology 19(8): 1893-1907
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12): 2893-2917
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2): 69-90
5. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R et al (2008) Cancer survival in five continents: a worldwide population-based study. Lancet Oncol 9(8): 730-756
6. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA (2010) Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 102(20): 1584-1598
7. NAACCR (2011) Surveillance, epidemiology and end results (SEER) program database (2011) CiNA Analytic File, 1995-2008, for expanded races, custom file with county, ACS facts and figures projection project, North American association of central cancer registries. www. seer. cancer. gov. Assessed 2011
8. National Cancer Institute (2012) SEER Surveillance, epidemiology, and end results registries. http: //seer. cancer. gov/registries/index. html. Assessed 19 April 2012
9. National Program of Cancer Registries (2012) Centers for disease control and prevention. http: //www. cdc. gov/cancer/npcr/about. htm. Assessed 6 April 2012
10. SEER (2011) Surveillance, epidemiology, and end results (SEER) program database www. seer. cancer. gov National cancer institute, DCCPS, surveillance research program, surveillance systems branch. Assessed April 2011
11. German RR, Fink AK, Heron M, Stewart SL, Johnson CJ, Finch JL et al (2011) The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol 35(2): 126-131
12. GLOBOCAN 2008 v1. 2 (2010) Cancer incidence and mortality worldwide: IARC CancerBase No.
13. International agency for research on cancer. http: //globocan. iarc. fr. Assessed 20, April 2012
14. Parkin DM (2006) The evolution of the population-based cancer registry. Nat Rev Cancer 6(8): 603-612
15. Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15(1): 36-47
16. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W et al (2011) SEER cancer statistics review, 1975-2008. National Cancer Institute Bethesda, Maryland
17. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53(6): 342-355
18. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D et al (2005) Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 97(6): 439-448
19. Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1): 49-56
20. Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR et al (2003) Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 95(20): 1545-1548
21. Gerend MA, Pai M (2008) Social determinants of Black-White disparities in breast cancer mortality: A review. Cancer epidemiology, biomarkers and prevention: A publication of the American association for cancer research, cosponsored by the American society of preventive oncology 17(11): 2913-2923
22. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295(21): 2492-2502
23. DeSantis C, Jemal A, Ward E (2010) Disparities in breast cancer prognostic factors by race, insurance status, and education. Cancer Causes Control 21(9): 1445-1450
24. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD et al (2009) Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national longitudinal mortality study. Cancer Causes Control 20(4): 417-435
25. Singh GK, Miller BA, Hankey BF, Edwards BK (2003) Area socioeconomic variations in U. S. Cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI cancer surveillance monograph series, number 4, Bethesda, Maryland
26. Klassen AC, Smith KC (2011) The enduring and evolving relationship between social class and breast cancer burden: a review of the literature. Cancer Epidemiol 35(3): 217-234
27. Desantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61(6): 409-418
28. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4): 212-236
29. Polednak AP (2005) Explaining geographic variation in breast and cervical cancer incidence rates in US Hispanic women. Ethn Dis 15(4): 727-732
30. Laden F, Spiegelman D, Neas LM, Colditz GA, Hankinson SE, Manson JE et al (1997) Geographic variation in breast cancer incidence rates in a cohort of U. S. women. J Natl Cancer Inst 89(18): 1373-1378
31. Canto MT, Anderson WF, Brawley O (2001) Geographic variation in breast cancer mortality for white and black women: 1986-1995. CA Cancer J Clin 51(6): 367-370
32. Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN (1995) Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 87(24): 1846-1853
33. Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the norwegian screening program. Ann of int med 156(7): 491-499
34. Wun LM, Feuer EJ, Miller BA (1995) Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control 6(2): 135-144
35. Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99(15): 1152-1161
36. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16): 1670-1674
37. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's health Initiative randomized controlled trial. JAMA 288(3): 321-333
38. Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U. S. women. Breast Cancer Res 9(3): R28
39. DeSantis C, Howlader N, Cronin KA, Jemal A (2011) Breast cancer incidence rates in U. S. women are no longer declining. Cancer epidemiology, biomarkers and prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive oncology 20(5): 733-739
40. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17): 1784-1792
41. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26(20): 3324-3330
42. CANCERMondial (2012) International agency for cancer research. http: //www-dep. iarc. fr. Assessed 20, April 2012
43. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85(22): 1819-1827
44. Tominaga S (1985) Cancer incidence in Japanese in Japan, Hawaii, and western United States. Natl Cancer Inst Monogr 69: 83-92
45. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer incidence in five continents, vol 8. Lyon, France
46. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14(2): 185-187
47. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010) Changing cancer incidence in Kampala, Uganda, 1991-2006. Int J Cancer 126(5): 1187-1195
48. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34(2): 405-412
49. Parkin DM (2009) Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer 45(9): 1649-1653
50. Seradour B, Allemand H, Weill A, Ricordeau P (2009) Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 96(4): E1-E6
51. Canfell K, Banks E, Moa AM, Beral V (2008) Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 188(11): 641-644
52. Peto R, Boreham J, Clarke M, Davies C, Beral V (2000) UK and USA breast cancer deaths down 25 % in year 2000 at ages 20-69 years. Lancet 355(9217): 1822
53. Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A et al (2008) Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit. Cancer 113(8): 2221-22243